Currently, Dr. Giuseppe Magistro is resident at the Department of Urology of the Ludwig-Maximilians-University (LMU), Munich (Germany), chaired by Prof. Christian G. Stief. He was raised in Munich and was educated at the Medical Faculty of the LMU. Afterwards, he worked for 3 years as a Post-Doc at the Max von Pettenkofer Institute for Hygiene and Clinical Microbiology of LMU, Munich.
In 2012, Dr. Magistro joined the LMU Department of Urology, where he headed the infection unit with its own microbiological diagnostic and experimental laboratory. At the same time, he started to specialize in benign conditions of the prostate. Under the supervision of Prof. Stief and Vice Chairman Prof. Christian Gratzke he was specially trained in BPH procedures comprising standard ablative procedures, enucleation techniques, as well as minimally invasive interventions.
Now, heading the BPH unit at the Department of Urology, Dr. Magistro’s main focus is on both clinical and experimental projects. The unit has special interest in the evaluation of emerging minimally invasive treatment options and the refinement of laser-based enucleation techniques. In the laboratory, studies are taking place on the roles of both inflammation and infection of the prostate for the development of benign conditions and malignancies.
Dr. Christopher Netsch was born in Frankfurt and raised in Germany. He studied medicine at the Universities of Mainz (DE) and Bern (CH). He graduated from the University of Mainz in 2005 and finished his doctoral thesis in 2006. His training in urology was conducted at the Inselspital Bern (under Prof. Studer), Städtisches Klinikum Karlsruhe (DE) (under Prof. Frohneberg) and the Asklepios Hospital Hamburg Barmbek (DE) (under Prof. Gross). After his board certification in 2011, Dr. Netsch became a staff member at the Department of Urology of the Asklepios Hospital Hamburg Barmbek. Here, he also attended a 24-month fellowship on Endourology (Fellow in Endourology, Endourological Society). He was qualified as a Fellow of the European Board of Urology (FEBU) in 2015. Dr. Netsch finished his habilitation thesis at Semmelweis University, Budapest (HU) in 2017.
Dr. Netsch is a member of the German Working Group in Endourology and the EAU section of Uro-Technology (ESUT) and a reviewer for numerous journals such as Urology, the British Journal of Urology International, the Journal of Endourology and the World Journal of Urology. He is also a member of the Editorial Board of the World Journal of Urology.
Dr. Christopher Netsch published over 70 PubMed listed, peer-reviewed journal articles, numerous book articles, published numerous abstracts, and hold lectures on national/international congresses. He was awarded with several awards both nationally and internationally such as the Wolfgang Mauermayer (first author) and the Winfried Vahlensieck (co-author) award of the German Society of Urology and the Hans Marberger (first author) award of the European Association of Urology. His scientific and clinical interests in urology are endourological topics: stone disease and minimally-invasive therapies for BPH.